| Glutamate and gamma-aminobutyric acid systems in the pathophysiology of major depression and antidepressant response to ketamine MS Lener, MJ Niciu, ED Ballard, M Park, LT Park, AC Nugent, ... Biological psychiatry 81 (10), 886-897, 2017 | 417 | 2017 |
| Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial JW Murrough, L Soleimani, KE DeWilde, KA Collins, KA Lapidus, ... Psychological medicine 45 (16), 3571-3580, 2015 | 314 | 2015 |
| Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression. ZC Lener MS, Kadriu B Drugs, 2017 | 120 | 2017 |
| In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature MS Lener, DV Iosifescu Annals of the New York Academy of Sciences 1344 (1), 50-65, 2015 | 111 | 2015 |
| White matter abnormalities in schizophrenia and schizotypal personality disorder MS Lener, E Wong, CY Tang, W Byne, KE Goldstein, NJ Blair, ... Schizophrenia bulletin 41 (1), 300-310, 2015 | 88 | 2015 |
| Parsing the heterogeneity of depression: An exploratory factor analysis across commonly used depression rating scales ED Ballard, JS Yarrington, CA Farmer, MS Lener, B Kadriu, N Lally, ... Journal of affective disorders 231, 51-57, 2018 | 84 | 2018 |
| Handedness, heritability, neurocognition and brain asymmetry in schizophrenia A Deep-Soboslay, TM Hyde, JP Callicott, MS Lener, BA Verchinski, ... Brain 133 (10), 3113-3122, 2010 | 78 | 2010 |
| Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder B Kadriu, PW Gold, DA Luckenbaugh, MS Lener, ED Ballard, MJ Niciu, ... Molecular psychiatry 23 (7), 1626-1631, 2018 | 59 | 2018 |
| Cortical abnormalities and association with symptom dimensions across the depressive spectrum MS Lener, P Kundu, E Wong, KE Dewilde, CY Tang, P Balchandani, ... Journal of affective disorders 190, 529-536, 2016 | 51 | 2016 |
| Neurophysiological changes associated with antidepressant response to ketamine not observed in a negative trial of scopolamine in major depressive disorder L Park, M Furey, AC Nugent, C Farmer, J Ellis, J Szczepanik, MS Lener, ... International Journal of Neuropsychopharmacology 22 (1), 10-18, 2019 | 39 | 2019 |
| Frontal release signs and cognition in people with schizophrenia, their siblings and healthy controls TM Hyde, TE Goldberg, MF Egan, MC Lener, DR Weinberger The British Journal of Psychiatry 191 (2), 120-125, 2007 | 34 | 2007 |
| A double-blind, placebo-controlled, pilot study of riluzole monotherapy for acute bipolar depression LT Park, MS Lener, M Hopkins, N Iadorola, R Machado-Vieira, E Ballard, ... Journal of clinical psychopharmacology 37 (3), 355-358, 2017 | 30 | 2017 |
| The effects of ketamine on typical and atypical depressive symptoms LT Park, DA Luckenbaugh, SJ Pennybaker, MA Hopkins, ID Henter, ... Acta Psychiatrica Scandinavica 142 (5), 394-401, 2020 | 20 | 2020 |
| The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder MJ Niciu, ND Iadarola, D Banerjee, DA Luckenbaugh, M Park, M Lener, ... Journal of Psychopharmacology 31 (12), 1570-1577, 2017 | 20 | 2017 |
| RGS4 and COMT risk variants are associated with brain structural alterations MS Lener, SJ Goodnow, JA Wood, KV Chowdari, MS Keshavan, ... Schizophrenia research 150 (1), 321-322, 2013 | 6 | 2013 |
| 330. A Principal Components Analysis of Depression and Anhedonia Scales: Illustrating the Heterogeneity of Depression E Ballard, D Luckenbaugh, J Yarrington, N Lally, M Lener, ... Biological Psychiatry 81 (10), S135, 2017 | 4 | 2017 |
| Clinical trial of the potassium channel activator diazoxide for major depressive disorder halted due to intolerability B Kadriu, S Yuan, C Farmer, AC Nugent, MS Lener, MJ Niciu, M Park, ... Journal of clinical psychopharmacology 38 (3), 243-246, 2018 | 3 | 2018 |
| RETRACTED: F173. Negative Trial of Scopolamine in Major Depressive Disorder Does Not Demonstrate Neurophysiological Changes Seen With the Antidepressant Response of Ketamine L Park, M Furey, A Nugent, C Farmer, J Ellis, J Szczepanik, M Lener, ... Biological Psychiatry 83 (9), S305-S306, 2018 | 3 | 2018 |
| 1003. Acute Ketamine Administration Corrects Abnormal Inflammatory Bone Markers in Major Depression B Kadriu, P Gold, M Lener, E Ballard, M Niciu, P Yuan, D Luckenbaugh, ... Biological Psychiatry 81 (10), S405-S406, 2017 | 1 | 2017 |
| 517. Effects of Ketamine on Atypical and Typical Symptoms of Depression K Yu, L Park, D Luckenbaugh, S Pennybaker, M Hopkins, M Lener, ... Biological Psychiatry 81 (10), S210, 2017 | 1 | 2017 |
Carlos ZarateNational Institute of Mental HealthDirección de correo verificada de mail.nih.gov
